SEATTLE, June 12, 2009 (GLOBE NEWSWIRE) -- Northstar Neuroscience, Inc. (Nasdaq:NSTR) announced today that is has provided written notice to The NASDAQ Stock Market, Inc. (“NASDAQ”) of its intention to voluntarily delist its common stock from the NASDAQ Global Market. On June 22, 2009, Northstar will file with the Securities and Exchange Commission and NASDAQ a Form 25 relating to the delisting of Northstar’s common stock. Northstar expects that trading in its common stock will be permanently suspended by NASDAQ effective at the open of trading on June 22, 2009, with official delisting of the common stock effective 10 days thereafter, on July 2, 2009, at which time Northstar’s transfer agent will close the stock transfer records and discontinue recording transfers of the common stock.
